Stereotactic body radiotherapy for T1 glottic cancer: dosimetric data in 27 consecutive patients
Abstract
Because the clinical feasibility of stereotactic body radiotherapy (SBRT) for early glottic cancer (T1) is controversial, we report dosimetric results in 27 consecutive patients from a prospective phase I and II study that started in 2017.In our approach, only the parts of the true vocal cord containing cancer and those immediately adjacent are planned to be treated to 36 Gy and 30 Gy, respectively, in 3 fractions. Several dosimetric metrics for...
Paper Details
Title
Stereotactic body radiotherapy for T1 glottic cancer: dosimetric data in 27 consecutive patients
Published Date
Apr 6, 2021
Journal
Volume
107
Issue
6
Pages
514 - 524
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History